During the past decade, Praxisklinik Krebsheilkunde fur Frauen conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Praxisklinik Krebsheilkunde fur Frauen" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Alliance Foundation Trials, LLC." with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "Aprea Therapeutics" with 1 trials sponsored and "Arcagy Research" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxisklinik Krebsheilkunde fur Frauen" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator and "NSABP Foundation Inc" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Praxisklinik Krebsheilkunde fur Frauen" are "Breast Cancer" (7 trials), "Breast Neoplasms" (1 trials), "Carcinoma Breast Stage IV" (1 trials), "Circulating Tumor Cells" (1 trials) and "Estrogen Receptor Positive Breast Cancer" (1 trials). Many other conditions were trialed in "Praxisklinik Krebsheilkunde fur Frauen" in a lesser frequency.

Most popular intervention types in "Praxisklinik Krebsheilkunde fur Frauen" are "Drug" (15 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Carboplatin" (3 trials), "trastuzumab" (3 trials), "Anastrozole" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Praxisklinik Krebsheilkunde fur Frauen" are 8 trials for "Female" genders and 7 trials for "All" genders.

Currently, there are NaN active trials in "Praxisklinik Krebsheilkunde fur Frauen". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Praxisklinik Krebsheilkunde fur Frauen, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Praxisklinik Krebsheilkunde fur Frauen, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".